Renovorx to participate in fireside chat at a.g.p. virtual healthcare company showcase on may 21st

Mountain view, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a life sciences company developing innovative targeted oncology therapies and commercializing renovocath©, a novel, fda-cleared drug-delivery device, today announced that chief executive officer, shaun bagai, will participate in a fireside chat at the alliance global partners (a.g.p.) virtual healthcare company showcase hosted by scott henry, managing director and healthcare analyst at a.g.p., o.
RNXT Ratings Summary
RNXT Quant Ranking